Evidence map›Paper›PMID 33301879›Full record

ReviewNeurobiology of disease2021

Overlaps, gaps, and complexities of mouse models of Developmental and Epileptic Encephalopathy.

Wanqi Wang, Wayne N Frankel

Abstract readReview
In one paragraph

Review in Neurobiology of disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Effective knockdown-replace gene therapy in a novel mouse model of DNM1 developmental and epileptic encephalopathy.Molecular therapy : the journal of the American Society of Gene Therapy · 2024
    Article
  9. New epilepsy therapies in development.Nature reviews. Drug discovery · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Frontiers in molecular neuroscience · 2023
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Clinical Trial Design for Disease-Modifying Therapies for Genetic Epilepsies.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Wanqi WangDepartment of Genetics & Development, Institute for Genomic Medicine, Columbia University Irving Medical Center, New York, NY, United States of America. Electronic address: ww2470@cumc.columbia.edu.
Wayne N FrankelDepartment of Genetics & Development, Institute for Genomic Medicine, Columbia University Irving Medical Center, New York, NY, United States of America. Electronic address: wf2218@cumc.columbia.edu.

Funding

GENETIC DETERMINANTS OF EPILEPSY IN MURINE SYSTEMSR01NS031348 · NINDS · JACKSON LABORATORY · PI SANDS, TRISTAN T · 1993 to 2025
$11.5M
PREDOCTORAL TRAINING GRANT IN HUMAN GENETICS &DEVELOPMET32GM007088 · NIGMS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI SHEN, MICHAEL M. · 1985 to 2020
$7.1M
Genetic Determinants of Epilepsy in Murine SystemsR37NS031348 · NINDS · JACKSON LABORATORY · PI FRANKEL, WAYNE N. · 2014 to 2020
$5.8M
NIGMS NIH HHS T32 GM007088NINDS NIH HHS R01 NS031348NINDS NIH HHS R37 NS031348
6 · The paper itself

Abstract

Mouse models have made innumerable contributions to understanding the genetic basis of neurological disease and pathogenic mechanisms and to therapy development. Here we consider the current state of mouse genetic models of Developmental and Epileptic Encephalopathy (DEE), representing a set of rare but devastating and largely intractable childhood epilepsies. By examining the range of mouse lines available in this rapidly moving field and by detailing both expected and unusual features in representative examples, we highlight lessons learned in an effort to maximize the full potential of this powerful resource for preclinical studies.

Indexed as

Disease Models, AnimalMiceAnimalsEpileptic SyndromesGain of Function MutationHumansInfantLoss of Function MutationMutation, MissensePhenotypeSeizuresSpasms, InfantileDisease modelingEpileptic encephalopathyMouse modelsSeizure

Identifiers

PMID33301879
PMCPMC8547712

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.